GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Thoratec Corporation (THOR) [hlAlert]

Rating:
Outperform
THOR
up 74.17 %

Thoratec Corporation (THOR) rated Outperform with price target $42 by Northland Securities

Posted on: Friday,  Sep 7, 2012  9:25 AM ET by Northland Securities

Northland Securities rated Outperform Thoratec Corporation (NASDAQ: THOR) on 09/07/2012, when the stock price was $35.82. Since
then, Thoratec Corporation has gained 74.18% as of 08/27/2015's recent price of $62.39.
If you would have followed this Northland Securities's recommendation on THOR, you would have gained 74.17% of your investment in 1084 days.

Thoratec Corporation (Thoratec) is a manufacturer of mechanical circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets medical devices used for circulatory support. It also develops, manufactures and markets point-of-care diagnostic test systems and skin incision products. Thoratec operates in two operating divisions: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. The Company conducts business both in the United States and internationally.

Our equity research effort attempts to identify high potential small-cap investment ideas. We offer traditional sell-side research services with a particular focus on unearthing information that either supports or challenges our investment thesis. We strive to continuously provide our institutional client base with timely and insightful thinking.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/7/2012 9:25 AM Buy
None
35.82 42.00
as of 12/31/2012
1 Week down  -0.68 %
1 Month up  0.86 %
3 Months up  8.43 %
1 YTD up  4.74 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy